Influence of blood-activating drugs on adhesive and invasive capability of tumor cells in lung cancer patients
β Scribed by Zhang Peitong; Pei Yingxia; Qi Xin; Piao Bingkui
- Publisher
- Chinese Association of Traditional and Western Medicine
- Year
- 1999
- Tongue
- English
- Weight
- 95 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1672-0415
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Lymphokine-activated killer (LAK) cell activity of peripheral blood mononuclear cells (PBM), spleen cells (SPC), regional lymph node cells (LNC), and tumor-infiltrating lymphocytes (TIL), induced by activation with interleukin 2 (IL 2) for 4 days, was evaluated in patients with gastric carcinoma. TI
## Abstract There is an unmet need for biomarkers for the prediction and monitoring of anticancer therapies. Here, we measured the concentrations of nucleosomes and DNA, protease and caspase activities in serum of 62 patients with ovarian cancer before and after firstβline carboplatin/taxaneβbased